Demitri Diakantonis

A weak September caps a slowing third quarter, with rate uncertainty and valuation gaps clouding the future.

Raising a first-time fund is challenging, but committed capital can help sponsors win deals and attract institutional backing—even as some prize the flexibility of investing deal by deal.

The Great Neck, N.Y.-based family office is diversifying its holdings through direct acquisitions, with plans to increase its deal size over time.

The final close marks Schroders' largest closed-ended commingled private equity fund to date, according to the company.

ADARx develops experimental RNA-based drugs for rare immune, kidney, cardiovascular and neurological diseases.